E-GEOD-848 - Transcription profiling of human MCF-7 breast cancer cells treated with E2, ICI 182,789 (ICI), Raloxifene (Ral), and/or trans-hydroxytamoxifen (TOT)
Submitted on 2 December 2003, released on 27 September 2007, last updated on 2 May 2014
MCF-7 breast cancer cells were treated with E2, ICI 182,789 (ICI), Raloxifene (Ral), and/or trans-hydroxytamoxifen (TOT) for 8 or 48 h. Duplicate samples are labeled set A or set B.
transcription profiling by array, co-expression, compound treatment, time series
Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Jonna Frasor, Fabio Stossi, Jeanne M Danes, Barry Komm, C Richard Lyttle, Benita S Katzenellenbogen. Cancer Res 64(4):1522-33 (2004)